Quince Therapeutics (QNCX)
NASDAQ:QNCX
US Market
Holding QNCX?
Track your performance easily

Quince Therapeutics (QNCX) Financial Statements

503 Followers

Quince Therapeutics Financial Overview

Quince Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.268; its P/E ratio is -0.60; Quince Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -27.69M$ -8.19M$ -4.89M$ -12.50M$ -6.07M
EBITDA$ -27.65M$ -8.14M$ -4.88M$ -12.48M$ -6.03M
Net Income Common Stockholders$ -27.73M$ -11.15M$ -4.89M$ -12.25M$ -5.52M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 51.55M$ 46.01M$ 64.92M$ 90.20M$ 90.18M
Total Assets$ 134.83M$ 159.29M$ 88.84M$ 93.31M$ 103.91M
Total Debt$ 14.29M$ 14.00M$ 0.00$ 0.00$ 0.00
Net Debt$ -37.27M$ -32.01M$ -64.92M$ -90.20M$ -90.18M
Total Liabilities$ 87.86M$ 85.11M$ 1.95M$ 3.12M$ 3.32M
Stockholders Equity$ 46.97M$ 74.18M$ 86.88M$ 90.22M$ 100.59M
Cash Flow-
Free Cash Flow$ -8.78M$ -8.39M$ -3.83M$ -3.62M$ -5.91M
Operating Cash Flow$ -8.74M$ -8.35M$ -3.83M$ -3.57M$ -5.83M
Investing Cash Flow$ -4.98M$ 8.91M$ -20.32M$ 5.54M$ 18.67M
Financing Cash Flow$ 35.00K$ 190.00K$ 26.00K$ 50.00K$ -18.00K
Currency in USD

Quince Therapeutics Earnings and Revenue History

Quince Therapeutics Debt to Assets

Quince Therapeutics Cash Flow

Quince Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis